MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$197,533K Marketable securities$154,773K Prepaid expenses andother current assets$5,174K Total property andequipment$18,471K Total current assets$357,480K Operating leaseright-of-use assets$4,241K Property and equipment,net$2,824K Restricted cash$1,201K Other assets$538K Less accumulateddepreciation$15,647K Total assets$366,284K Total liabilities andstockholders equity$366,284K Total stockholdersequity$349,000K Total liabilities$17,284K Accumulated deficit-$594,278K Additional paid-in capital$943,037K Total currentliabilities$13,048K Operating leaseliability, excluding...$4,039K Other liabilities,excluding current portion$197K Accumulated othercomprehensive gain$174K Common stock, 0.001 parvalue 200,000,000...$67K Accrued expenses andother current...$9,052K Operating leaseliability, current$2,404K Accounts payable$1,592K
Balance Sheet
source: myfinsight.com

Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics, Inc. (FULC)